NIKKEI 225
38,810.95 -112.08 (-0.29%) HANG SENG
18,403.04 +323.43 (+1.79%) CRUDE OIL
74.01 -0.21 (-0.28%) GOLD FUTURES
2,371.20 +1.90 (+0.08%) DOW
38,571.03 -115.29 (-0.30%) Bitcoin GBP
53,798.13 +975.65 (+1.85%)
Eli Lilly and Company (LILY34.SA)
- Benzinga
Eli Lilly Beefs Up Neuro Pipeline With Addition Of Preclinical ALS, Dementia Prospect
On Monday, privately held QurAlis Corporation entered into an exclusive license agreement with Eli Lilly and Co. (NYSE:LLY). QurAlis has granted Lilly global rights to develop and commercialize QRL-204, a splice-switching antisense oligonucleotide (ASO) designed to restore UNC13A function in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases. Under the terms of the agreement, QurAlis granted Lilly an exclusive, worldwide license to develop an
- Investor's Business Daily
Beyond The Nvidia Juggernaut: 2 Chip Giants, 2 Drugmakers In Spotlight
As Nvidia stock takes aim at another record high and market-cap dominance, AMD and TSM set up alongside two top drugmakers.
- Investor's Business Daily
LLY Stock Today: How To Trade An Unbalanced Iron Condor That May Put $285 In Your Pocket
You can achieve this type of iron condor by trading more put spreads than call spreads. As a reminder, an iron condor is a combination of a bull put spread and a bear call spread. This spread could also be sold for around $0.95.
